Clearbrook is featured in this CNBC Investigative report regarding the consumption of opioid pain medication in America. CNBC Reporter, Dina Gusovsky went behind the scenes to gather the facts of the big business of opioid pain medication and the devastating effects that results from their abuse. During her investigation, Clearbrook was asked to share our knowledge about the addiction these drugs fuel and the lives they shatter.
Richard Conaboy, Vice President at Clearbrook, and a recent Clearbrook alumni, offer their insight and experience with the opioid epidemic in an interview filmed at Clearbrook Manor in Wilkes Barre, PA.
Excerpt from CNBC Article | Approximately 80 percent of the global opioid supply is consumed in the United States. Pain drugs are the second-largest pharmaceutical class globally, after cancer medicines. “There was about 300 million pain prescriptions written in 2015,” Irina Koffler, senior analyst, specialty pharma, Mizuho Securities USA, told CNBC.
The 300 million pain prescriptions equal a $24 billion market, Koffler said, but it’s not a market evenly divided around the globe. Rampant use of opioids in the United States, which represents only 5 percent of the global population, points to a larger divide between affluent nations and the rest of the world when it comes to prescription painkillers.
Please visit CNBC.com to read the full article that accompanies this investigative video.